project files added

resources/app/var/entitaeten.txt

@@ -0,0 +1,12 @@
+Astrozytom
+Bronchialkarzinom
+Cholangiokarzinom
+Ependymom
+Glioblastom
+Mammakarzinom
+Melanom
+Meningeom
+NUT-Midline Karzinom
+Pankreaskarzinom
+Sigmakarzinom
+Zervixkarzinom

resources/app/var/medikamente.txt

@@ -0,0 +1,84 @@
+Ado-trastuzumab emtansine (Kadcyla)
+Afatinib (Gilotrif)
+Aldesleukin (Proleukin)
+Alectinib (Alecensa)
+Alemtuzumab (Campath)
+Atezolizumab (Tecentriq)
+Avelumab (Bavencio)
+Axitinib (Inlyta)
+Belimumab (Benlysta)
+Belinostat (Beleodaq)
+Bevacizumab (Avastin)
+Blinatumomab (Blincyto)
+Bortezomib (Velcade)
+Bosutinib (Bosulif)
+Brentuximab vedotin (Adcetris)
+Brigatinib (Alunbrig)
+Cabozantinib (Cabometyx [tablet], Cometriq [capsule])
+Canakinumab (Ilaris)
+Carfilzomib (Kyprolis)
+Ceritinib (Zykadia)
+Cetuximab (Erbitux)
+Cobimetinib (Cotellic)
+Crizotinib (Xalkori)
+Dabrafenib (Tafinlar)
+Daratumumab (Darzalex)
+Dasatinib (Sprycel)
+Denosumab (Xgeva)
+Dinutuximab (Unituxin)
+Durvalumab (Imfinzi)
+Elotuzumab (Empliciti)
+Enasidenib (Idhifa)
+Erlotinib (Tarceva)
+Everolimus (Afinitor)
+Gefitinib (Iressa)
+Ibritumomab tiuxetan (Zevalin)
+Ibrutinib (Imbruvica)
+Idelalisib (Zydelig)
+Imatinib (Gleevec)
+Ipilimumab (Yervoy)
+Ixazomib (Ninlaro)
+Lapatinib (Tykerb)
+Lenvatinib (Lenvima)
+Midostaurin (Rydapt)
+Necitumumab (Portrazza)
+Neratinib (Nerlynx)
+Nilotinib (Tasigna)
+Niraparib (Zejula)
+Nivolumab (Opdivo)
+Obinutuzumab (Gazyva)
+Ofatumumab (Arzerra, HuMax-CD20)
+Olaparib (Lynparza)
+Olaratumab (Lartruvo)
+Osimertinib (Tagrisso)
+Palbociclib (Ibrance)
+Panitumumab (Vectibix)
+Panobinostat (Farydak)
+Pazopanib (Votrient)
+Pembrolizumab (Keytruda)
+Pertuzumab (Perjeta)
+Ponatinib (Iclusig)
+Ramucirumab (Cyramza)
+Regorafenib (Stivarga)
+Ribociclib (Kisqali)
+Rituximab (Rituxan, Mabthera)
+Rituximab/hyaluronidase human (Rituxan Hycela)
+Romidepsin (Istodax)
+Rucaparib (Rubraca)
+Ruxolitinib (Jakafi)
+Siltuximab (Sylvant)
+Sipuleucel-T (Provenge)
+Sonidegib (Odomzo)
+Sorafenib (Nexavar)
+Temsirolimus (Torisel)
+Tocilizumab (Actemra)
+Tofacitinib (Xeljanz)
+Tositumomab (Bexxar)
+Trametinib (Mekinist)
+Trastuzumab (Herceptin)
+Vandetanib (Caprelsa)
+Vemurafenib (Zelboraf)
+Venetoclax (Venclexta)
+Vismodegib (Erivedge)
+Vorinostat (Zolinza)
+Ziv-aflibercept (Zaltrap)